Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. UMP Healthcare Holdings's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.37%.
UMP Healthcare Holdings (HKSE:00722) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UMP Healthcare Holdings (HKSE:00722) has a ROCE % of 6.37% as of Dec. 2025.
Is UMP Healthcare Holdings' ROCE % too high?
UMP Healthcare Holdings' current ROCE % is 6.37%. The Healthcare Providers & Services industry median ROCE % is 6.64. UMP Healthcare Holdings' value of 6.37% is 4% below this industry median. Overall, UMP Healthcare Holdings has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UMP Healthcare Holdings' ROCE % compare to HCA and THC?
UMP Healthcare Holdings' ROCE % of 6.37% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.64. UMP Healthcare Holdings' value of 6.37% is 4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.64, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UMP Healthcare Holdings's current ROCE % of 6.37% is 4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UMP Healthcare Holdings's current ROCE % is 6.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UMP Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, UMP Healthcare Holdings (HKSE:00722) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.49, compared to a current price of HK$0.45 — trading 9.2% below its estimated fair value. The current ROCE % is 6.37% and 4% below the Healthcare Providers & Services industry median of 6.64. UMP Healthcare Holdings' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For UMP Healthcare Holdings (HKSE:00722), the current ROCE % is 6.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UMP Healthcare Holdings (HKSE:00722) Overvalued in 2026?
Based on GuruFocus' analysis, UMP Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.45 is trading 9.2% below its estimated GF Value™ of HK$0.49.
GuruFocus considers UMP Healthcare Holdings to be Fairly Valued.
Key valuation signals for HKSE:00722:
ROCE %: 6.37%
GF Value™: HK$0.49 vs. price of HK$0.45 (9.2% below fair value)
Industry Position: 4% below the Healthcare Providers & Services median
No single metric tells the full story. See the HKSE:00722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UMP Healthcare Holdings Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the provision of healthcare services that include corporate healthcare solution services, medical and dental services, medical imaging and laboratory services, other auxiliary medical services, and healthcare management services. The reportable operating business segments are Hong Kong & Macau Clinical Healthcare Services, which derives maximum revenue; Hong Kong & Macau Corporate Healthcare Solution Services; and Mainland China Clinical Healthcare Services. Its geographical segments include Hong Kong, Mainland China, and Macau, of which the majority of its revenue comes from Hong Kong.
56GF Score
Get the complete analysis for HKSE:00722
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00722 has been successfully added to your 
